{
  "docId": "019de073-9e32-71bd-acba-301a2d9cbf00",
  "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c",
  "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 28,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "roadmap",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 3,
  "notes": "The slide uses a Gantt-style bar chart to represent clinical trial phases for each drug program.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/5",
  "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00",
  "deckJsonHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00.json",
  "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.26,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Clinical development status bars for four programs",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db742943-b985-4749-9f35-427ee500ac2d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.82
      },
      "kind": "source-note",
      "text": "Detailed footnotes regarding patient estimates and licensing agreements.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "019ac947-3215-4606-aef8-8c6630cf4d07",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "table",
      "text": "Pipeline table with columns: Program, Research, Phase 1/2, Phase 3, Regulatory Review, Addressable Market, Geographic Rights",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1f329d25-6a3b-461c-b877-da54526a2d35",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Aeglea's Human Enzyme Platform for Rare Metabolic Diseases",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43d3a7c1-e2c7-4dc2-9419-aee752af8f29",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "7f8e1473-32cf-4f8f-ab7d-1238bd6d536c",
      "evidence": "table/data: Pipeline table",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "1df117ff-ed19-4e26-830a-16ea4bfd0fb4",
      "evidence": "Horizontal bars representing development phases over time",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}